Clinical implications of aldo-keto reductase family 1 member C3 and its relationship with lipocalin 2 in cancer of the uterine cervix-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical implications of aldo-keto reductase family 1 member C3 and its relationship with lipocalin 2 in cancer of the uterine cervix

Published:2014-02 Issue:2 Volume:132 Page:474-482
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Wu Chih-Hsien,Ko Jiunn-Liang,Chen Shiuan-Chih,Lin Yu-Wen,Han Chih-Ping,Yang Ti-Yuan,Chien Ming-Hsien,Wang Po-Hui

Funder

Taiwan National Science Council

Chung Shan Medical University Hospital

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference39 articles.

1. The aldo-keto reductase superfamily homepage;Hyndman;Chem Biol Interact,2003

2. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones;Penning;Biochem J,2000

3. Steroid hormone transforming aldo-keto reductases and cancer;Penning;Ann N Y Acad Sci,2009

4. Human aldo-keto reductases: function, gene regulation, and single nucleotide polymorphisms;Penning;Arch Biochem Biophys,2007

5. AKR1C isoforms represent a novel cellular target for jasmonates alongside their mitochondrial-mediated effects;Davies;Cancer Res,2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis;2024-05-08

2. AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategies;Frontiers in Pharmacology;2024-03-08

3. In vitroandin vivoevidences propound therapeutic potential of Lipocalin 2 in cervical carcinoma;2023-01-14

4. ARID3A promotes the chemosensitivity of colon cancer by inhibiting AKR1C3;Cell Biology International;2022-03-16

5. Systems Pharmacology Study of the Anticervical Cancer Mechanisms of FDY003;Natural Product Communications;2020-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3